Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial

Aim: To verify the superiority of pemafibrate over placebo and the non-inferiority of pemafibrate to the maximum dose of fenofibrate for determining the percent change in fasting serum triglyceride (TG) levels and to investigate safety by assessing the incidence of adverse events (AEs) and adverse d...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Atheroscler Thromb
Autori principali: Arai, Hidenori, Yamashita, Shizuya, Yokote, Koutaro, Araki, Eiichi, Suganami, Hideki, Ishibashi, Shun
Natura: Artigo
Lingua:Inglês
Pubblicazione: Japan Atherosclerosis Society 2018
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6005227/
https://ncbi.nlm.nih.gov/pubmed/29628483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.44412
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi